Cargando…
Effectiveness of combined low-dose radiotherapy and pazopanib for controlling the local manifestations of taxane-resistant recurrent angiosarcoma of the head
Autores principales: | Kato, Hiroshi, Nakamura, Motoki, Oda, Takao, Morita, Akimichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369525/ https://www.ncbi.nlm.nih.gov/pubmed/32715058 http://dx.doi.org/10.1016/j.jdcr.2020.06.006 |
Ejemplares similares
-
Surgical Resection and Pazopanib Treatment for Recurrent Cardiac Angiosarcoma
por: Nakamura, Yuki, et al.
Publicado: (2019) -
Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures
por: Magara, Tetsuya, et al.
Publicado: (2023) -
Pazopanib in Primary Cardiac Angiosarcoma of the Right Atrium: A Case Report
por: Schur, Sophie, et al.
Publicado: (2016) -
Cutaneous angiosarcoma treated with taxane‐based chemoradiotherapy: A multicenter study of 90 Japanese cases
por: Fujimura, Taku, et al.
Publicado: (2022) -
Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
por: Sakaida, Takashi, et al.
Publicado: (2020)